| Enhancement of curcumin bioavailability via the prodrug approach: Challenges and prospects P Ratnatilaka Na Bhuket, A El-Magboub, IS Haworth, P Rojsitthisak European journal of drug metabolism and pharmacokinetics 42, 341-353, 2017 | 46 | 2017 |
| Evaluation of in-class and online discussion meetings in a biopharmaceutics problem-based learning class A El-Magboub, IS Haworth, BT Sutch, RM Romero Currents in Pharmacy Teaching and Learning 8 (6), 811-820, 2016 | 28 | 2016 |
| Naturally occurring sesquiterpene lactones and their semi-synthetic derivatives modulate PGE2 levels by decreasing COX2 activity and expression F Perri, L Frattaruolo, I Haworth, M Brindisi, A El-Magboub, A Ferrario, ... Heliyon 5 (3), 2019 | 23 | 2019 |
| Rational drug design and synthesis of new α-Santonin derivatives as potential COX-2 inhibitors A Coricello, A El-Magboub, M Luna, A Ferrario, IS Haworth, CJ Gomer, ... Bioorganic & medicinal chemistry letters 28 (6), 993-996, 2018 | 21 | 2018 |
| Biological targets and pharmacology of curcumin A El-Magboub, P Rojsitthisak, C Muangnoi, W Wichitnithad, RM Romero, ... Curcumin: Synthesis, Emerging Role in Pain Management and Health …, 2014 | 6 | 2014 |
| A revival of primary healing hypotheses: a comparison of traditional healing approaches of Arabs and American Indians AS El-Magboub University of Southern California, 2011 | 6 | 2011 |
| Curcumin: synthesis, emerging role in pain management and health implications A El-Magboub, P Rojsitthisak, C Muangnoi, W Wichitnithad, RM Romero, ... Nova Science, 103-134, 2014 | 5 | 2014 |
| Computational Models for Drug Design and Delivery AS El-Magboub University of Southern California, 2017 | 1 | 2017 |
| Design, synthesis and biological activities of curcumin prodrugs P Rojsitthisak, W Wichitnithad, C Muangnoi, A El-Magboub, RM Romero, ... Curcumin: synthesis, emerging role in pain management and health …, 2014 | 1 | 2014 |
| Corrigendum to “Naturally occurring sesquiterpene lactones and their semi-synthetic derivatives modulate PGE2 levels by decreasing COX2 activity and expression”[Heliyon 5 (3 … F Perri, L Frattaruolo, I Haworth, M Brindisi, A El-Magboub, A Ferrario, ... Heliyon 5 (4), 2019 | | 2019 |
| Rational drug design and synthesis of new o-Santonin derivatives as potential COX-2 inhibitors A Coricello, A El-Magboub, M Luna, A Ferrario, IS Haworth, CJ Gomer, ... | | 2018 |
